An additional SNP associated with MASLD is the variant in the Hydroxysteroid 17-beta dehydrogenase 13 (HSD17B13) gene, which plays a key role in retinoid metabolism through its enzymatic activity and catalyzing retinol oxidation to retinaldehyde [18]. This evidence concerns the gene HSD17B13 and metabolic dysfunction-associated steatotic liver disease.